NANOS 2018 Literature Review Clinical Papers Neurology. Caroline Tilikete, MD, PhD Hospices Civils de Lyon, University Lyon I Lyon, France

Size: px
Start display at page:

Download "NANOS 2018 Literature Review Clinical Papers Neurology. Caroline Tilikete, MD, PhD Hospices Civils de Lyon, University Lyon I Lyon, France"

Transcription

1 NANOS 2018 Literature Review Clinical Papers Neurology Caroline Tilikete, MD, PhD Hospices Civils de Lyon, University Lyon I Lyon, France

2 Nystagmus Effect of Gabapentin/Memantine on the Infantile Nystagmus Syndrome in the Zebrafish Model Bogli SY, Afthinos M, Huang MY. Invest Ophthalmol Vis Sci. 2017;58(7):

3 Nystagmus Magnetic Oculomotor Prosthetics for Acquired Nystagmus. Nachev P, Rose GE, Verity DH, Manohar SG, MacKenzie K, Adams G, et al. Ophthalmology. 2017;124(10):

4 Nystagmus Resolution of periodic alternating nystagmus with amantadine. Lee SH, Lee SY, Choi SM, Kim BC, Kim MK, Kim JS. J Neurol Sci. 2016;364:65-7.

5 Vestibular testing in INO Vestibulo-ocular reflex deficits with medial longitudinal fasciculus lesions. Aw ST, Chen L, Todd MJ, Barnett MH, Halmagyi GM. J Neurol. 2017;264(10): Impaired vestibular responses in internuclear ophthalmoplegia: Association and dissociation. Choi SY, Kim HJ, Kim JS. Neurology Nov 15 Severe deficit of contralesional posterior semicircular canal (SCC) function

6 MOG associated optic neuritis Clinical presentation and prognosis in MOG-antibody disease: a UK study. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Brain. 2017;140(12): Clinical presentation isolated optic neuritis : 55%, bilateral in almost half transverse myelitis: 18% acute disseminated encephalomyelitis-like presentations : 18% Pronostic 16% patients of bad visual acuity (<6/36) in at least 1 eye 7% EDSS > 4 ; 5% EDSS > 6 28% bladder issues, 20% bowel dysfunction and 21% erectile dysfunction Annualized relapse rate 0,2 Decreased with immunosuppression > 3 months

7 MOG associated optic neuritis Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. Deschamps R, Lecler A, Lamirel C, Aboab J, Gueguen A, Bensa C, et al. Eur J Neurol. 2017;24(6):875 10% ON-MOG What proportion of AQP4-IgGnegative NMO spectrum disorder patients are MOG-IgG positive? Hamid SHM, Whittam D, Mutch K, Linaker S, Solomon T, Das K, et al. J Neurol. 2017;264(10): % MOG-IgG positive

8 MOG associated optic neuritis Optic neuritis in patients with anti-mog antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France. Biotti D, Bonneville F, Tournaire E, Ayrignac X, Dalliere CC, Mahieu L, et al. Journal of Neurology. 2017;264(10): optic nerve head swelling Extensive optic nerve T2 hyperintensity with gadolinium enhancement

9 MOG associated optic neuritis MOG-ab as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Havla J, Kumpfel T, Schinner R, Spadaro M, Schuh E, Meinl E, et al. J Neurol. 2017;264(1): MOG-ab>AQP4-ab Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study. Stiebel-Kalish H, Lotan I, Brody J, Chodick G, Bialer O, Marignier R, et al. PLoS One. 2017;12(1):e AQP4-ab>MOG-ab

10 Diagnostic MRI criteria for NMOSD Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease. Jurynczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, et al. J Neurol Neurosurg Psychiatry. 2017;88(2): lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe 2. subcortical U-fibre lesion 3. Dawson s finger-type lesion sensitivity 90.9% specificity 89.7%

11 Paraneoplastic NMOSD Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Sepulveda M, Sola-Valls N, Escudero D, Rojc B, Baron M, Hernandez-Echebarria L, et al. Multiple sclerosis. 2017: In NMOSD, the risk for cancer is higher in patients who present with brainstem involvement, mainly nausea and vomiting patients older than 45 years, usually male, presenting with extensive transverse myelitis

12 PLEX treatment of NMOSD Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. Bonnan M, Valentino R, Debeugny S, Merle H, Ferge JL, Mehdaoui H, et al. J Neurol Neurosurg Psychiatry. 2017

13 Posterior cerebral atrophy (PCA) Consensus classification of posterior cortical atrophy. Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, et al. Alzheimers Dement. 2017;13(8):870-84

14 Multiple Sclerosis Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Lancet Neurol In a patient with a typical clinical isolated syndrome (CIS) and fulfilment of clinical or MRI criteria for "dissemination in space" and no better explanation for the clinical presentation, demonstration of CSF-specific oligoclonal bands allows an MS diagnosis to be made without the previously required "dissemination in time. 2. Both symptomatic and asymptomatic MRI lesions can be used for fulfilling MRI criteria for dissemination in space or dissemination in time. 3. In addition to juxtacortical lesions, cortical lesions can also be used to demonstrate dissemination in space requirements. 4. The group also declined to include the presence of optic neuritis pathology in the revised criteria

15 MS Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, et al. Lancet Neurol. 2017;16(3):189-99

New Insights on Optic Neuritis in Young People

New Insights on Optic Neuritis in Young People Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Study New Insights on Optic Neuritis in Young People Sergio Carmona 1, Sandra Barbosa 1 and Maria Laura Ortube 2 * 1 Department of Neuro-ophthalmology, Hospital

More information

MRI and differential diagnosis in patients suspected of having MS

MRI and differential diagnosis in patients suspected of having MS Andrea Falini Italy MRI and differential diagnosis in patients suspected of having MS IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Outline of presentation - Diagnostic criteria

More information

Patologie infiammatorie encefaliche e midollari

Patologie infiammatorie encefaliche e midollari Patologie infiammatorie encefaliche e midollari Maria Laura Stromillo Department of Medicine, Surgery and Neuroscience Inflammatory disorders of the CNS NMOSD ADEM Multiple Sclerosis Neuro-Myelitis Optica

More information

Magnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome)

Magnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome) J Radiol Sci 2012; 37: 45-50 Magnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome) Chien-Chuan Huang Tai-Yuan Chen Tai-Ching Wu Yu-Kun Tsui Te-Chang Wu Wen-Sheng Tzeng Chien-Jen Lin Department

More information

Actualização no diagnóstico e tratamento das doenças desmielinizantes na infância. Silvia Tenembaum

Actualização no diagnóstico e tratamento das doenças desmielinizantes na infância. Silvia Tenembaum Actualização no diagnóstico e tratamento das doenças desmielinizantes na infância Silvia Tenembaum Acquired CNS inflammatory/demyelinating disorders: Background information More frequent in children than

More information

NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS

NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS Jeffrey A. Cohen, MD Director, Experimental Therapeutics Mellen MS Center Neurological Institute Cleveland Clinic 2018 Regional MS Summit 30 June 2018 Disclosures

More information

Neuromyelitis optica (NMO), or Devic s disease, is a rare

Neuromyelitis optica (NMO), or Devic s disease, is a rare Case Report Neuromyelitis Optica (NMO) Abstract NMO is a is a rare entity which involves the central nervous system acting as an inflammatory process by attacking the optic nerve (ON) and longitudinally

More information

Myelitis. Case 2. History. Examination. Mahtab Ghadiri

Myelitis. Case 2. History. Examination. Mahtab Ghadiri Case 2 Myelitis Mahtab Ghadiri History A 42-year-old man presented to the emergency department with altered sensation in the lower limbs and difficulty ambulating. He first noted paresthesia in his feet

More information

Sawada J, Orimoto R, Misu T, Katayama T, Aizawa H, Asanome A, Takahashi K, Saito T, Anei R, Kamada K, Miyokawa N, Takahashi T, Fujihara K, Hasebe N.

Sawada J, Orimoto R, Misu T, Katayama T, Aizawa H, Asanome A, Takahashi K, Saito T, Anei R, Kamada K, Miyokawa N, Takahashi T, Fujihara K, Hasebe N. Mult Scler (2014.9) 20(10):1413-1416. A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.

More information

COPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED

COPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED The Transverse Myelitis Association...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)

More information

Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore

Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore Case Reports 26 Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore Koh Yeow Hoay, Pavanni Ratnagopal Abstract Introduction: Neuromyelitis optica (NMO)

More information

Heterogeneity of Demyelinating Disease: Definitions and Overlap Overview

Heterogeneity of Demyelinating Disease: Definitions and Overlap Overview Heterogeneity of Demyelinating Disease: Definitions and Overlap Overview Brian Weinshenker, MD, FRCP(C) Disclosures Royalties related to patent for discovery of NMO-IgG licensed to RSR Ltd; Oxford University

More information

Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis

Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis 24-25 February 2016 - Siena, Italy Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org How

More information

Idiopathic Inflammatory Demyelinating Diseases of the Brainstem

Idiopathic Inflammatory Demyelinating Diseases of the Brainstem Idiopathic Inflammatory Demyelinating Diseases of the Brainstem 1 A. Rovira-Cañellas, 2 A. Rovira-Gols, 1 J. Sastre-Garriga, 1 C. Auger, 1 J. Munuera, 1 X. Montalban 1 Hospital Vall d Hebron, Barcelona.

More information

Wingerchuk et al, Neurol, 2006

Wingerchuk et al, Neurol, 2006 Current Understanding of Neuromyelitis Optica Jacqueline A. Leavitt, M.D. Mayo Clinic Rochester, MN I have no financial disclosures 46 y/o F Pain in R temple worse with head movements, resolved in days

More information

Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study

Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study Magnus Spangsberg Boesen November, 2016 Supervisors: P. Born, P. Uldall, M. Blinkenberg, M. Magyari, F. Sellebjerg

More information

Neurological update: MOG antibody disease

Neurological update: MOG antibody disease https://doi.org/10.1007/s00415-018-9122-2 NEUROLOGICAL UPDATE Neurological update: MOG antibody disease Ray Wynford Thomas 1,2 Anu Jacob 3 Valentina Tomassini 1,2,4 Received: 17 August 2018 / Revised:

More information

MRI in Differential Diagnosis. CMSC, June 2, Jill Conway, MD, MA, MSCE

MRI in Differential Diagnosis. CMSC, June 2, Jill Conway, MD, MA, MSCE MRI in Differential Diagnosis CMSC, June 2, 2016 Jill Conway, MD, MA, MSCE Director, Carolinas MS Center Clerkship Director, UNCSOM-Charlotte Campus Charlotte, NC Disclosures Speaking, consulting, and/or

More information

Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis

Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis JCN Open Access pissn 1738-6586 / eissn 2005-5013 / J Clin Neurol 2018;14(3):387-392 / https://doi.org/10.3988/jcn.2018.14.3.387 ORIGINAL ARTICLE Clinical Application of 2017 McDonald Diagnostic Criteria

More information

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY John R. Rinker, II, MD University of Alabama at Birmingham June 2, 2016 DISCLOSURES Research Support: Biogen Idec; Department of

More information

PMH: No medications; Immunizations UTD No hospitalizations or surgeries Speech Delay. Birth Hx: 24 WGA, NICU x6 months

PMH: No medications; Immunizations UTD No hospitalizations or surgeries Speech Delay. Birth Hx: 24 WGA, NICU x6 months HPI: 6 months of weakness and parathesias- originally in both feet x 2-3 months, then resolved. Now with parathesias and weakness in fingers x 1 week. Seen by podiatrist and given custom in-soles 1 month

More information

Multiple sclerosis in Japan: Nationwide surveys over 30 years

Multiple sclerosis in Japan: Nationwide surveys over 30 years Neurology Asia 28; 13 : 131 143 Multiple sclerosis in Japan: Nationwide surveys over 3 years Jun-ichi Kira, Takaaki Ishizu, Manabu Osoegawa, and The Research Committee of Neuroimmunological Diseases Department

More information

Setting the Scene: Neuromyelitis Optica epidemiology, population variability, subgroups: relapsing/monophasic, Ab +ve/-ve, NMO/SD, treated/untreated

Setting the Scene: Neuromyelitis Optica epidemiology, population variability, subgroups: relapsing/monophasic, Ab +ve/-ve, NMO/SD, treated/untreated UK Nationally Commissioned NMO team Setting the Scene: Neuromyelitis Optica epidemiology, population variability, subgroups: relapsing/monophasic, Ab +ve/-ve, NMO/SD, treated/untreated Jackie Palace Disclosures

More information

Magnetic Resonance Imaging in the Acquired Demyelinating Disorders: A Pediatric Cohort Study

Magnetic Resonance Imaging in the Acquired Demyelinating Disorders: A Pediatric Cohort Study Journal of Pharmacy and Pharmacology 6 (2018) 20-31 doi: 10.17265/2328-2150/2018.01.003 D DAVID PUBLISHING Magnetic Resonance Imaging in the Acquired Demyelinating Disorders: A Pediatric Cohort Study Santa

More information

Research Article Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese Multiple Sclerosis

Research Article Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese Multiple Sclerosis International Scholarly Research Network ISRN Neurology Volume 211, Article ID 9476, 4 pages doi:1.542/211/9476 Research Article Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese

More information

RSR RSR RSR RSR RSR. ElisaRSR AQP4 Ab RSR. Aquaporin-4 Autoantibody Assay Kit

RSR RSR RSR RSR RSR. ElisaRSR AQP4 Ab RSR. Aquaporin-4 Autoantibody Assay Kit To aid diagnosis of Neuromyelitis Optica (NMO) and NMO spectrum disorder (NMOSD) To confirm diagnosis before initial treatment of patients with demyelinating inflammatory disease NMO, NMOSD and AQP4 Elisa

More information

Endpoints in a treatment trial in NMO: Clinician s view. Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK

Endpoints in a treatment trial in NMO: Clinician s view. Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK Endpoints in a treatment trial in NMO: Clinician s view Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK 1 The greatest challenge to any thinker is stating the problem in a way that will

More information

MYELITIS. A Mochan Neurology

MYELITIS. A Mochan Neurology MYELITIS A Mochan Neurology ATM MS LETM NMOSD ATM LETM MS NMOSD Acute Transverse Myelitis Longitudinally Extensive Transverse Myelitis Multiple Sclerosis Neuromyelitis Optica Spectrum Disorders ATM ADEM

More information

The role of anti-aquaporin-4 antibody in Asian patients with multiple sclerosis: Confusions and controversies

The role of anti-aquaporin-4 antibody in Asian patients with multiple sclerosis: Confusions and controversies Neurology Asia 2007; 12 : 135 139 VIEWS AND REVIEW The role of anti-aquaporin-4 antibody in Asian patients with multiple sclerosis: Confusions and controversies HT Chong, *AG Kermode, CT Tan Department

More information

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis AJNR Am J Neuroradiol 21:702 706, April 2000 Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis Mar Tintoré, Alex

More information

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island #CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Use of MRI in Clinical Decision- Making

More information

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas,

More information

Disease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019

Disease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019 Disease of Myelin Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019 1 I HAVE NO CONFLICTS OF INTEREST OR DISCLOSURES TO DECLARE. I HAVE NO

More information

Myelitis. Myelitis. Multiple Sclerosis (MS) Acute demyelinating syndrome (ADS) Indictions for spinal cord MRI in MS.

Myelitis. Myelitis. Multiple Sclerosis (MS) Acute demyelinating syndrome (ADS) Indictions for spinal cord MRI in MS. Myelitis Myelitis Majda M Thurnher Professor of Radiology Medical University of Vienna University Hospital Vienna Department of Biomedical Imaging and Image-Guided Therapy Vienna Austria Acute demyelinating

More information

Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment

Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment doi: 10.2169/internalmedicine.9840-17 Intern Med 57: 3307-3312, 2018 http://internmed.jp CASE REPORT Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal

More information

Hot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018

Hot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Hot Topics Multiple Sclerosis Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Disclosures Natalie Parks has received compensation from Biogen, EMD Serono, Roche, and Sanofi

More information

Clinically isolated syndromes (CIS) may

Clinically isolated syndromes (CIS) may RECOGNIZING AND MANAGING THE CLINICALLY ISOLATED SYNDROME* Steven L. Galetta, MD ABSTRACT Clinically isolated demyelinating syndromes, such as optic neuritis, transverse myelitis, and brain-stem disorders,

More information

Multiple sclerosis. Tünde Csépány MD. PhD

Multiple sclerosis. Tünde Csépány MD. PhD Multiple sclerosis Tünde Csépány MD. PhD. 11. 19. 2008. Multiple Sclerosis Approximately 350 000 people in the United States are affected by MS Prevalence strongly dependent on latitude (25-224/100 000

More information

Interactive Cases: Demyelinating Diseases and Mimics. Disclosures. Case 1 25 yo F with nystagmus; look for tumor 4/14/2017

Interactive Cases: Demyelinating Diseases and Mimics. Disclosures. Case 1 25 yo F with nystagmus; look for tumor 4/14/2017 Interactive Cases: Demyelinating Diseases and Mimics Disclosures None Brad Wright, MD 27 March 2017 Case 1 25 yo F with nystagmus; look for tumor What do you suspect? A. Demyelinating disease B. Malignancy

More information

CURRICULUM VITAE. Young Eun Huh, MD, PhD

CURRICULUM VITAE. Young Eun Huh, MD, PhD CURRICULUM VITAE Young Eun Huh, MD, PhD NATIONALITY: South Korea LICENSURE or CERTIFICATION: 2004 Medical license (83710) 2009 Certificates of competency, neurology (1230) EDUCATION and TRAINING: 2004

More information

GILENYA (fingolimod) oral capsule

GILENYA (fingolimod) oral capsule GILENYA (fingolimod) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

TECFIDERA (dimethyl fumarate) oral capsule

TECFIDERA (dimethyl fumarate) oral capsule TECFIDERA (dimethyl fumarate) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Provider Led Entity. CDI Quality Institute PLE Multiple Sclerosis (MS) AUC

Provider Led Entity. CDI Quality Institute PLE Multiple Sclerosis (MS) AUC Provider Led Entity CDI Quality Institute PLE Multiple Sclerosis (MS) AUC Appropriateness of advanced imaging procedures* in patients with the following clinical presentations or diagnoses: 09/04/2018

More information

Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases

Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases Peripheral neuropathies according to which part affected Axonal Demyelinating with axonal sparing Many times: mixed features

More information

1st interactive course in MS advanced managment

1st interactive course in MS advanced managment 6-7 December - Toronto, Canada 1st interactive course in MS advanced managment IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Liesly Lee Sunnybrook Health Sciences Centre. Department

More information

1 MS Lesions in T2-Weighted Images

1 MS Lesions in T2-Weighted Images 1 MS Lesions in T2-Weighted Images M.A. Sahraian, E.-W. Radue 1.1 Introduction Multiple hyperintense lesions on T2- and PDweighted sequences are the characteristic magnetic resonance imaging (MRI) appearance

More information

Helpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI

Helpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI Helpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI This information is provided as an educational resource for healthcare providers and should be considered current

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acetazolamide, in idiopathic intracranial hypertension, 49 52, 60 Angiography, computed tomography, in cranial nerve palsy, 103 107 digital

More information

The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica

The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica Neurology Asia 2014; 19(4) : 375 385 The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica 1,2 Sasitorn Siritho MD, 3 Metha Apiwattanakul MD, 1 Naraporn Prayoonwiwat MD

More information

PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day

PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 6 PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M

More information

Fatigue And Beyond How Vision Captures Disease in MS

Fatigue And Beyond How Vision Captures Disease in MS Fatigue And Beyond How Vision Captures Disease in MS Salim Chahin, MD Fellow Multiple Sclerosis University of Pennsylvania Outline Introduction. Visual function testing disease outcomes. Optical Coherence

More information

MRI Imaging of Neuromyelitis Optica

MRI Imaging of Neuromyelitis Optica July 2009 MRI Imaging of Neuromyelitis Optica Jenna Nolan, Harvard Medical School Year III Gillian Lieberman, MD Our Patient: Initial Presentation J.H. is a 29 year-old woman who presents with acute vision

More information

Patient-reported outcomes, biomarkers and novel methodologies, and their role in the development of new multiple sclerosis medicines

Patient-reported outcomes, biomarkers and novel methodologies, and their role in the development of new multiple sclerosis medicines Patient-reported outcomes, biomarkers and novel methodologies, and their role in the development of new multiple sclerosis medicines Frank Dahlke MD, Novartis Pharma AG on behalf of efpia 1 Patient Reported

More information

Title: Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases.

Title: Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases. Author's response to reviews Title: Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases. Authors: Martin Voss (Martin.Voss@kgu.de) Felix Bischof (Felix.Bischof@uni-tuebingen.de)

More information

Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow

Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow Reading: Robbins & Cotran, 9 th edition, pp 1283-1286 Robbins Basic Pathology, 9 th edition, 832-835 Overview: Grossly, myelin is

More information

Salintip Kunadison MD, Chaiwiwat Tungkasereerak MD, Surin Saetang MD, Pawut Mekawichai MD

Salintip Kunadison MD, Chaiwiwat Tungkasereerak MD, Surin Saetang MD, Pawut Mekawichai MD Neurology Asia 2018; 23(1) : 55 59 Comparison of clinical features between aquaporin-4 antibody seropositive and seronegative patients in neuromyelitis optica and neuromyelitis optica spectrum disorder

More information

ORIGINAL CONTRIBUTION. Multiple Sclerosis That Is Progressive From the Time of Onset

ORIGINAL CONTRIBUTION. Multiple Sclerosis That Is Progressive From the Time of Onset ORIGINAL CONTRIBUTION Multiple Sclerosis That Is Progressive From the Time of Onset Clinical Characteristics and Progression of Disability P. B. Andersson, MBChB, DPhil; E. Waubant, MD; L. Gee, MPH; D.

More information

MRI in MS. MRI in multiple sclerosis. MS T2 Lesions: Pathology. Brain lesions Morphology Matters. Sagittal FLAIR Morphology Matters

MRI in MS. MRI in multiple sclerosis. MS T2 Lesions: Pathology. Brain lesions Morphology Matters. Sagittal FLAIR Morphology Matters MRI in multiple sclerosis MRI in MS Rohit Bakshi, MD, MA Breakstone Professor of Neurology & Radiology Director, Laboratory for Neuroimaging Research Senior Neurologist, MS Center Brigham & Women s Hospital

More information

MRI features and anti-aqp4 antibody status in Idiopathic inflammatory demyelinating CNS disease (IIDCD) in Thai patients

MRI features and anti-aqp4 antibody status in Idiopathic inflammatory demyelinating CNS disease (IIDCD) in Thai patients Neurology Asia 2013; 18(1) : 73 81 MRI features and anti-aqp4 antibody status in Idiopathic inflammatory demyelinating CNS disease (IIDCD) in Thai patients 1 Naraporn Prayoonwiwat MD, 2 Orasa Chawalparit

More information

Professor Yasser Metwally. Neuromyelitis optica. EPIDEMIOLOGY

Professor Yasser Metwally. Neuromyelitis optica.  EPIDEMIOLOGY 180 Professor Yasser Metwally Neuromyelitis optica www.yassermetwally.com N EPIDEMIOLOGY Afro-Caribbean, and South American descent implying underlying genetic mechanisms in the expression of demyelinating

More information

Soliris in NMOSD Phase 3 PREVENT Study Topline Results September 24, 2018

Soliris in NMOSD Phase 3 PREVENT Study Topline Results September 24, 2018 Soliris in NMOSD Phase 3 PREVENT Study Topline Results September 24, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Ocular Oscillations and Transient Oscillopsia in Neuromyelitis Optica

Ocular Oscillations and Transient Oscillopsia in Neuromyelitis Optica Elmer ress Case Report J Neurol Res. 2014;4(5-6):145-149 Ocular Oscillations and Transient Oscillopsia in Neuromyelitis Optica Nitin Nema a, c, Abha Verma a, Urvija Choudhary a, Pramod Sakhi b Abstract

More information

ORIGINAL CONTRIBUTION. Painful Tonic Spasm in Neuromyelitis Optica. Incidence, Diagnostic Utility, and Clinical Characteristics

ORIGINAL CONTRIBUTION. Painful Tonic Spasm in Neuromyelitis Optica. Incidence, Diagnostic Utility, and Clinical Characteristics ORIGINAL CONTRIBUTION Painful Tonic Spasm in Neuromyelitis Optica Incidence, Diagnostic Utility, and Clinical Characteristics Sung-Min Kim, MD; Min Jin Go, MS; Jung-Joon Sung, MD, PhD; Kyung Seok Park,

More information

NIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2012 July 1.

NIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2012 July 1. NIH Public Access Author Manuscript Published in final edited form as: Arch Neurol. 2011 July ; 68(7): 870 878. doi:10.1001/archneurol.2011.34. Beneficial Plasma Exchange Response in CNS Inflammatory Demyelination

More information

Neurophysiology in diagnosis and monitoring of MS

Neurophysiology in diagnosis and monitoring of MS ISTITUTO SCIENTIFICO UNIVERSITARIO SAN RAFFAELE MS Academia Amsterdam - October 18, 2011 Neurophysiology in diagnosis and monitoring of MS Letizia Leocani Dep.t of Neurology, Clin. Neurophysiol. and Neurorehabilitation

More information

MRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis. E.W. Radue K. Bendfeldt Till Sprenger

MRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis. E.W. Radue K. Bendfeldt Till Sprenger MRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis E.W. Radue K. Bendfeldt Till Sprenger Medical Image Analysis Center University Hospital Basel www. miac.ch

More information

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

MRI dynamics of brain and spinal cord in progressive multiple sclerosis J7ournal of Neurology, Neurosurgery, and Psychiatry 1 996;60: 15-19 MRI dynamics of brain and spinal cord in progressive multiple sclerosis 1 5 D Kidd, J W Thorpe, B E Kendall, G J Barker, D H Miller,

More information

Multiple sclerosis. Tünde Csépány MD. PhD. 08. November 2017.

Multiple sclerosis. Tünde Csépány MD. PhD. 08. November 2017. Multiple sclerosis Tünde Csépány MD. PhD. 08. November 2017. Multiple Sclerosis Approximately 350 000 people in the United States are affected by MS Prevalence strongly dependent on latitude (25-224/100

More information

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY John R. Rinker II, MD University of Alabama at Birmingham Birmingham VA Medical Center May 29, 2014 DISCLOSURES Salary/Research:

More information

AUBAGIO (teriflunomide) oral tablet

AUBAGIO (teriflunomide) oral tablet AUBAGIO (teriflunomide) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

The Etiological Spectrum of Acute Sensory Myelitis

The Etiological Spectrum of Acute Sensory Myelitis Open Access pissn 1738-6586 / eissn 2005-5013 / J Clin Neurol 2015;11(3):227-233 / http://dx.doi.org/10.3988/jcn.2015.11.3.227 ORIGINAL ARTICLE Jae-Won Hyun a,c Jee Young Kim b Kyung Gyu Choi a Ho Jin

More information

BRAINSTEM SYNDROMES OF NEURO-OPHTHALMOLOGICAL INTEREST

BRAINSTEM SYNDROMES OF NEURO-OPHTHALMOLOGICAL INTEREST BRAINSTEM SYNDROMES OF NEURO-OPHTHALMOLOGICAL INTEREST Steven L. Galetta, MD NYU Langone Medical Center New York, NY I. Anatomical Considerations The brain stem is about the size of a fat forefinger and

More information

Spinal cord MR imaging in Multiple Sclerosis

Spinal cord MR imaging in Multiple Sclerosis 43ème CONGRÈS ANNUEL de la Société Française de NeuroRadiologie 30 mars au 1 er avril 2016 Novotel Paris Tour Eiffel Spinal cord MR imaging in Multiple Sclerosis Àlex Rovira Unitat de Neurorradiología.

More information

Severe visual loss due to optic neuritis (ON) is the most

Severe visual loss due to optic neuritis (ON) is the most Ocular Oscillations in the Neuromyelitis Optica Spectrum Rabih Hage, Jr, MD, Harold Merle, MD, Séverine Jeannin, MD, Philippe Cabre, MD Abstract: Four French West Indian women complained of oscillopsia

More information

ORIGINAL CONTRIBUTION. Long-term Follow-up of Acute Partial Transverse Myelitis

ORIGINAL CONTRIBUTION. Long-term Follow-up of Acute Partial Transverse Myelitis ORIGINAL CONTRIBUTION Long-term Follow-up of Acute Partial Transverse Myelitis Bertrand Bourre, MD; Hélène Zéphir, MD; Jean-Claude Ongagna, CRA; Charlotte Cordonnier, MD, PhD; Nicolas Collongues, MD; Stephanie

More information

Blood Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability

Blood Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability The Journal of International Medical Research 2012; 40: 1483 1491 Blood Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability

More information

Pearls, Pitfalls and Advances in Neuro-Ophthalmology

Pearls, Pitfalls and Advances in Neuro-Ophthalmology Pearls, Pitfalls and Advances in Neuro-Ophthalmology Nancy J. Newman, MD Emory University Atlanta, GA Consultant for Gensight Biologics, Santhera Data Safety Monitoring Board for Quark AION Study Medical-legal

More information

MULTIPLE SCLEROSIS - REVIEW AND UPDATE

MULTIPLE SCLEROSIS - REVIEW AND UPDATE MULTIPLE SCLEROSIS - REVIEW AND UPDATE Luka Vlahovic, MD Neuroimmunology/Multiple Sclerosis Creighton University Medical Center MS is primary demyelinating disease of the central nervous system. MS is

More information

Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score

Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score This section should only be completed by a neurologist or MD / ROD (Medical Doctor / Resident on Duty) involved in the

More information

Role of MRI in acute disseminated encephalomyelitis

Role of MRI in acute disseminated encephalomyelitis Original Research Article Role of MRI in acute disseminated encephalomyelitis Shashvat Modiya 1*, Jayesh Shah 2, C. Raychaudhuri 3 1 1 st year resident, 2 Associate Professor, 3 HOD and Professor Department

More information

Multiple Sclerosis (MS) is a

Multiple Sclerosis (MS) is a The role of interferon beta in multiple sclerosis management David J Rog MRCP, John P Mottershead MRCP, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Manchester, M6 8HD SPL Multiple

More information

Program Highlights. A multidisciplinary AAN working group identified areas for improvement in the diagnosis and management of patients with MS

Program Highlights. A multidisciplinary AAN working group identified areas for improvement in the diagnosis and management of patients with MS CasePerspectives: Illuminating Dark Pathways in Complex MS Cases Program Highlights Stephen Krieger, MD Associate Professor of Neurology Corinne Goldsmith Dickinson Center for MS Director, Neurology Residency

More information

The Multiple Sclerosis Lesion Checklist

The Multiple Sclerosis Lesion Checklist The Multiple Sclerosis Lesion Checklist A clinician s guide to evaluating brain MRI in a patient with improbable multiple sclerosis. By Ilya Kister, MD, FAAN Paraphrasing W.B. Matthews about dizziness,

More information

Optic Neuritis and Multiple Sclerosis

Optic Neuritis and Multiple Sclerosis Part I Optic Nerve Chapter 1 Optic Neuritis and Multiple Sclerosis Edward J. Atkins, Valérie Biousse, Nancy J. Newman 1 Core Messages Idiopathic optic neuritis, an isolated inflammatory optic neuropathy

More information

Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background

Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis Victoria A Levasseur 1,2, Samantha Lancia 1, Gautam Adusumilli 1, Zach Goodman 1, Stuart D. Cook 3, Diego Cadavid 4, Robert T.

More information

CNS demyelination and quadrivalent HPV vaccination

CNS demyelination and quadrivalent HPV vaccination SHORT REPORT Multiple Sclerosis 2009; 15: 116 119 CNS demyelination and quadrivalent HPV vaccination I Sutton 1,2, R Lahoria 3, IL Tan 1, P Clouston 4 and MH Barnett 2,3 Vaccination is generally considered

More information

Neuromyelitis Optica Spectrum Disorder (NMOSD): Brain MRI findings in patients at our institution and literature review.

Neuromyelitis Optica Spectrum Disorder (NMOSD): Brain MRI findings in patients at our institution and literature review. Neuromyelitis Optica Spectrum Disorder (NMOSD): Brain MRI findings in patients at our institution and literature review. Poster No.: C-0817 Congress: ECR 2014 Type: Educational Exhibit Authors: G. I. MICHELIN,

More information

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease MEDIA BACKGROUNDER Multiple Sclerosis: A serious and unpredictable neurological disease Multiple sclerosis (MS) is a complex chronic inflammatory disease of the central nervous system (CNS) that still

More information

PRIMARY DISEASES OF MYELIN

PRIMARY DISEASES OF MYELIN PRIMARY DISEASES OF MYELIN Acquired forms - Characterized by preferential damage to previously normal myelin with relative preservation of axons and include: 1. Immune-mediated injury, such as multiple

More information

The Role of MRI in Multiple Sclerosis

The Role of MRI in Multiple Sclerosis September 2006 The Role of MRI in Multiple Sclerosis David Cochran, Harvard Medical School Year IV Meet our patient WM 49yoF presents to Multiple Sclerosis Clinic for follow-up regarding worsening symptoms

More information

Transverse Myelitis and Myelopathy in the VA system: Etiology and Epidemiology

Transverse Myelitis and Myelopathy in the VA system: Etiology and Epidemiology Transverse Myelitis and Myelopathy in the VA system: Etiology and Epidemiology Stacey L. Clardy MD PhD Staff Neurologist, Salt Lake City VA Assistant Professor of Neurology, University of Utah Director,

More information

Clinical differences between young and older patients with optic neuritis

Clinical differences between young and older patients with optic neuritis Original Article Page 1 of 5 Clinical differences between young and older patients with optic neuritis Wenjing Luo 1 *, Qiu-Shui Huang 2 *, Jian-Feng He 2, Min Han 1, Bo Liu 1, Yi Du 2 1 The Cadre Ward

More information

Brainstorming the Case: An unusual presentation of autoimmune encephalitis

Brainstorming the Case: An unusual presentation of autoimmune encephalitis Brainstorming the Case: An unusual presentation of autoimmune encephalitis Alyssa Tilly, MD, LeeAnne Flygt, MD, MA, Ashley Sutton, MD UNC Chapel Hill Department of Pediatrics Disclosure of Financial Relationships

More information

Ocrevus (ocrelizumab)

Ocrevus (ocrelizumab) Ocrevus (ocrelizumab) Policy Number: 5.01.629 Last Review: 04/2018 Origination: 05/2017 Next Review: 04/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Ocrevus

More information

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Neuromyelitis Optica Spectrum Disorder (NMOSD) Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare relapsing autoimmune disorder that preferentially causes inflammation in the optic nerve and spinal

More information

Diagnostic Criteria, Clinical Courses, and Rating Scales in MS

Diagnostic Criteria, Clinical Courses, and Rating Scales in MS Diagnostic Criteria, Clinical Courses, and Rating Scales in MS Introduction and Objectives Introduction This module will focus on diagnostic tools utilized in randomized clinical trials (RCTs) in MS. Diagnostic

More information

MULTIPLE SCLEROSIS PROFILE

MULTIPLE SCLEROSIS PROFILE MULTIPLE SCLEROSIS PROFILE What is Multiple Sclerosis? Multiple sclerosis (MS) is a chronic, inflammatory disease of unknown etiology that involves an immune-mediated attack on the central nervous system

More information

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders 655264TAN0010.1177/1756285616655264Therapeutic Advances in Neurological DisordersEH Martinez-Lapiscina, M Sepulveda research-article2016 Therapeutic Advances in Neurological Disorders Letter to the Editor

More information

Clinical Case Study Discussion of Demyelinating Diseases. Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011

Clinical Case Study Discussion of Demyelinating Diseases. Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011 Clinical Case Study Discussion of Demyelinating Diseases Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011 No financial disclosures Will discuss use of non-fda approved medication CONTENT Case

More information

Anaesthesia recommendations for patients suffering from Neuromyelitis optica spectrum disorder

Anaesthesia recommendations for patients suffering from Neuromyelitis optica spectrum disorder orphananesthesia Anaesthesia recommendations for patients suffering from Neuromyelitis optica spectrum disorder Disease name: Neuromyelitis optica spectrum disorder ICD 10: G36.0 Synonyms: Devic's Disease,

More information